Amninder Singh

Amninder Singh, MD, is an experienced professional in the field of pharmacovigilance and drug safety, currently serving as the Director of Pharmacovigilance and Drug Safety at Xenon Pharmaceuticals Inc. through July 2024. Previously, Amninder Singh held significant roles as Director of Medical Safety Science at Ascendis Pharma and Director of Global Patient Safety and Risk Management Physician at Aimmune Therapeutics. Earlier positions include Drug Safety Physician roles at Quark Pharmaceuticals and Actelion. Amninder Singh's background reflects a strong commitment to ensuring patient safety and risk management within the pharmaceutical industry.